Table 3 Type 2 diabetes case–control and incidence analysis rs615563 (G/A)
From: Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
Non-Diabetic | Diabetic | OR (%95 CI)a | p-value | |
|---|---|---|---|---|
Type 2 diabetes case–control analysis (n = 590) | ||||
GG | 270 (82.3%) | 58 (17.7%) | 1.78 (0.79–4.44) | 0.16 |
GA | 183 (89.3%) | 22 (10.7%) | Reference | |
AA | 47 (82.5%) | 10 (17.5%) | 1.48(0.84–2.61) | 0.17 |
Allele frequency | ||||
G | 72.3% | 77% | ||
A | 27.7% | 23% | ||
Type 2 diabetes incidence analysis (n = 580) | ||||
GG | 270 (83.6%) | 53 (16.4%) | 1.55 (0.85–4.39) | 0.16 |
GA | 183 (90.6%) | 19 (9.4%) | Reference | |
AA | 47 (85.5%) | 8 (14.5%) | 1.72 (0.84–2.61) | 0.26 |
Allele frequency | ||||
G | 72.3% | 78% | ||
A | 27.7% | 22% | ||